GAIN THERAPEUTICS, INC Stock Split Ratio
GAIN THERAPEUTICS, INC (GANX) had Stock Split Ratio of 100.00% as of 2021-03-18, per its 10-Q filed 2021-11-12.
Discontinued › Notes
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2024-03-26
- 2021-03-18: Stockholders' Equity Note, Stock Split, Conversion Ratio 100.00%.
- 2021-03-17: Stockholders' Equity Note, Stock Split, Conversion Ratio 100.00%; Stockholders' Equity Note, Stock Split, Conversion Ratio as first filed 88.08%.
- 2021-03-03: Stockholders' Equity Note, Stock Split, Conversion Ratio 113.54%; Stockholders' Equity Note, Stock Split, Conversion Ratio as first filed 88.08%.
- 2020-07-20: Stockholders' Equity Note, Stock Split, Conversion Ratio 1000.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio as first filed |
|---|---|---|
| 2021-03-18 | 100.00% 10-Q · filed 2021-11-12 | |
| 2021-03-17 | 100.00% 10-K · filed 2022-03-25 | 88.08% 10-Q · filed 2021-05-10 |
| 2021-03-03 | 113.54% 10-K · filed 2023-03-23 | 88.08% 10-Q · filed 2021-05-10 |
| 2020-07-20 | 1000.00% 10-K · filed 2024-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B |